CD4 and neoplasm: Previous studies demonstrated that TME contexture, including tumor-infiltrating CD4+/CD8+ T cells, macrophage M1, natural killer cells, and inflammatory cytokines, played vital roles in tumor progression and immunotherapeutic efficacy [18, 52].